Ubiquitination/ Proteasome
- Autophagy(1374)
- DUB(28)
- E1 Activating(1)
- E2 conjugating(1)
- E2 Ligases(0)
- E3 Ligase(8)
- Proteasome(123)
- p97(12)
- Mitophagy(104)
- ULK(10)
Products for Ubiquitination/ Proteasome
- Cat.No. Product Name Information
- GN10103 Neferine
- GC13793 NH125 Selective eEF-2 kinase inhibitor
- GC65072 Niacin-13C6
- GC10678 Nicardipine HCl Nicardipine HCl (YC-93) is a calcium channel blocker with an IC50 of 1 μM for blocking cardiac calcium channels.
- GC44400 Niclosamide (ethanolamine salt) Niclosamide (BAY2353) olamine is an orally active antihelminthic agent used in parasitic infection research.
- GC36736 Nicodicosapent Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
- GC13206 Nicotinic Acid Nicotinic Acid (Vitamin B3) is an orally active water-soluble B3 vitamin that is an essential nutrient for humans.
-
GC34686
Nidufexor
An FXR partial agonist
- GC15024 Nifedipine L-type calcium channel blocker
- GC14237 Nilotinib monohydrochloride monohydrate A Bcr-Abl inhibitor
- GC16587 Nimodipine Calcium Channel inhibitor & Autophagy activator
- GC11618 Nitazoxanide Antiprotozoal agent
- GC16999 Nitrendipine Calcium channel blocker
- GC34009 Nitroprusside disodium dihydrate (Sodium nitroprusside dihydrate) Nitroprusside disodium dehydrate (Sodium nitroprusside dihydrate) is a vasodilator that available for the research of acute hypertension, heart failure.
- GC11365 Nitroxoline antibacterial agent
- GC39411 NL-1 NL-1 is a mitoNEET inhibitor with antileukemic effect. NL-1 inhibits REH and REH/Ara-C cells growth with IC50s of 47.35 ?M and 56.26 ?M, respectively. NL-1-mediated death in leukemic cells requires the activation of the autophagic pathway.
- GC32874 NMS-859 NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
- GC17250 NMS-873 VCP/p97 inhibitor,selective and allosteric
- GN10325 Nobiletin
- GC14075 Nocodazole A tubulin production inhibitor,anti-neoplastic agent
- GC50113 Noradrenaline bitartrate Norepinephrine (Levarterenol; L-Noradrenaline) tartrate is a potent adrenergic receptor (AR) agonist.
- GC10976 Noradrenaline bitartrate monohydrate Norepinephrine (Levarterenol; L-Noradrenaline) bitartrate monohydrate is a potent adrenergic receptor (AR) agonist.
- GC18089 Nordihydroguaiaretic acid A non-selective LO inhibitor
- GC30744 Norepinephrine (Adrenor) Norepinephrine (Adrenor) (Levarterenol; L-Noradrenaline) is a potent adrenergic receptor (AR) agonist.
- GC36758 Norepinephrine hydrochloride Norepinephrine (Levarterenol; L-Noradrenaline) hydrochloride is a potent adrenergic receptor (AR) agonist.
- GC64076 Nortriptyline Nortriptyline (Desmethylamitriptyline), the main active metabolite of Amitriptyline, is a tricyclic antidepressant used to relieve the symptoms of depression.
- GC11989 Nortriptyline (hydrochloride) norepinephrine and serotonin transporters blocker
- GC32821 Noscapine ((S,R)-Noscapine)
- GC39023 Notoginsenoside Fc Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation.
-
GC16486
Novobiocin Sodium
aminocoumarin antibiotic
- GC12424 NS 1643 hERG KV11.1 channel activator
- GC44464 NSC 109555 An inhibitor of Chk2
- GC34924 NSC 185058 An inhibitor of ATG4B
- GC15017 NSC 624206 Ubiquitin-activating enzyme (E1) inhibitor
- GC12475 NSC 632839 hydrochloride A deubiquitylase and deSUMOylase inhibitor
- GC11932 NSC697923 Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective
- GC10470 Nutlin-3a chiral An inhibitor of the p53-Mdm2 interaction
- GC12963 NVP-AEW541 IGF-IR inhibitor, novel, potent and selective
- GC16145 NVP-BGT226 BGT226 (NVP-NVP-BGT226) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3Kα, PI3Kβ and PI3Kγ) /mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells.
- GC11569 Obatoclax mesylate (GX15-070) An antagonist of pro-survival Bcl-2 proteins
- GC14158 Obeticholic Acid A FXR agonist with anticholeretic activity
- GC64358 Olacaftor Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408.
- GC12495 Olanzapine Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM).
- GC61809 Olanzapine D3 Olanzapine D3 (LY170053-d3) is the deuterium labeled Olanzapine.
-
GC17580
Olaparib (AZD2281, Ku-0059436)
A PARP inhibitor
- GN10184 Oleanolic acid
- GC49815 Oleuropein aglycone A polyphenol with diverse biological activities
- GC13166 Omeprazole H+,K+-ATPase inhibitor
- GC36806 Omeprazole D3 Omeprazole D3 (H 16868-d3) is deuterium labeled Omeprazole.
- GC61155 Omeprazole sodium Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders.
- GC64070 Omeprazole-d3-1
- GN10332 Onjisaponin B
- GC15778 ONX-0914 (PR-957) A selective inhibitor of the β5i (LMP7) subunit of the immunoproteasome
- GC62210 ONX-0914 TFA ONX-0914 (PR-957) TFA is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome.
- GC15447 Oprozomib (ONX-0912) An orally available proteasome inhibitor
- GC39260 OR-1855 OR-1855, an active metabolite of Levosimendan, has effect on human myometrial contractility.
- GN10732 Oroxin B
-
GC41625
Oroxylin A
Oroxylin A is a flavonoid that has been found in S.
- GC14071 OSI-027 MTORC1/ mTORC2 inhibitor
- GC15742 OSU-03012 (AR-12) Potent PDK1 inhibitor
- GC36821 OSU-T315 OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). OSU-T315 abrogates AKT activation by impeding AKT localization in lipid rafts and triggers caspase-dependent apoptosis in an ILK-independent manner. OSU-T315 causes cell death through apoptosis and autophagy.
-
GC10579
Ouabain Octahydrate
selective Na+/K+-ATPase inhibitor
- GC17716 Oxaliplatin Oxaliplatin is a cytotoxic chemotherapy drug used to treat cancer.
- GC30871 Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride) Oxidopamine (6-OHDA) hydrochloride is an antagonist of the neurotransmitter dopamine.
- GC33446 Oxyphenisatin acetate Oxyphenisatin acetate, the pro-drug of oxyphenisatin, is used to be a laxative.
- GC33464 Oxyresveratrol (trans-Oxyresveratrol) Oxyresveratrol (trans-Oxyresveratrol) (trans-Oxyresveratrol (trans-Oxyresveratrol)) is a potent naturally occurring antioxidant and free radical scavenger (IC50 of 28.9 μM against DPPH free radicals).
- GC10379 P 22077
-
GC12067
P005091
P005091 is a potent and selective ubiquitin-specific proteinase 7 (USP7) inhibitor with an EC50 value of 4.2 μM.
- GC33008 p38 MAPK-IN-1 p38 MAPK-IN-1 (Compound 4) is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM.
- GC30609 p38 MAPK-IN-2 p38 MAPK-IN-2 is an inhibitor of p38 kinase.
- GC31988 p38α inhibitor 1 p38α inhibitor 1 is a p38α inhibitor extracted from patent WO 2008076265 A1.
- GC30158 p38-α MAPK-IN-1 p38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay.
- GC38562 P62-mediated mitophagy inducer P62-mediated mitophagy inducer is a mitophagy regulator which activates mitophagy without recruiting Parkin or collapsing ΔΨm and retains activity in cells devoid of a fully functional PINK1/Parkin pathway.
- GC11993 PAC-1 An in vitro procaspase-3 activator
-
GC12511
Paclitaxel (Taxol)
A potent mitotic inhibitor
- GN10498 Paeonol
-
GC69650
Paeonol-d3
Paeonol-d3 is deuterated Paeonol.
-
GC14304
Palovarotene
Selective retinoic acid receptor gamma(RAR-γ) agonist
- GC15814 Pamapimod (R-1503, Ro4402257) Pamapimod (R-1503, Ro4402257) (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1.3 nM and 120 nM for p38α and p38β, respectively.
- GC12257 Panobinostat (LBH589) A pan-HDAC inhibitor
- GC12718 Pantoprazole H+/K+-ATPase inhibitor
- GC36847 Pantoprazole sodium Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI).
- GC36848 Pantoprazole sodium hydrate Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI).
- GC36855 Paris saponin VII Paris saponin VII (Chonglou Saponin VII) is a steroidal saponin isolated from the roots and rhizomes of Trillium tschonoskii Maxim. Paris saponin VII-induced apoptosis in K562/ADR cells is associated with Akt/MAPK and the inhibition of P-gp. Paris saponin VII attenuates mitochondrial membrane potential, increases the expression of apoptosis-related proteins, such as Bax and cytochrome c, and decreases the protein expression levels of Bcl-2, caspase-9, caspase-3, PARP-1, and p-Akt. Paris saponin VII induces a robust autophagy in K562/ADR cells and provides a biochemical basis in the treatment of leukemia.
- GC17229 Paroxetine HCl Paroxetine HCl is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an and has GRK2 inhibitory ability with IC50 of 14μM.
- GC30992 Paroxetine hydrochloride hemihydrate (BRL29060 hydrochloride hemihydrate) Paroxetine hydrochloride hemihydrate (BRL29060 hydrochloride hemihydrate) is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an antidepressant and has GRK2 inhibitory ability with IC50 of 14μM.
- GN10357 Parthenolide
- GC16327 Pazopanib (GW-786034) A multi-kinase inhibitor
- GC12730 Pazopanib Hydrochloride VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor
- GC12205 PD 146176 PD 146176 is one of the potent and selective inhibitors of reticulocyte 15-LOX-1.
- GC16912 PD 150606 An inhibitor of calpains
- GC10561 PD 151746 calpain inhibitor, cell-permeable
- GC17737 PD 169316 P38 MAPK inhibitor
- GC19279 PD-166866 PD166866 is a selective FGFR1 tyrosine kinase inhibitor with an IC50 of 52.4 nM.
-
GC10397
PD0325901
A MEK inhibitor that sustains stem cell renewal
- GC11015 PD168393 EGFR inhibitor
-
GC12819
PD98059
PD98059 is a potent and selective MEK inhibitor with an IC50 of 2 μM.
- GN10084 Peiminine
- GC11610 Pemetrexed An antifolate with anticancer activity
- GC17694 Pemetrexed disodium hemipenta hydrate